Therapeutic opportunities in polyglutamine disease |
| |
| Authors: | Hughes R E Olson J M |
| |
| Affiliation: | Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA. rehughes@u.washington.edu |
| |
| Abstract: | Polyglutamine diseases comprise a class of familial neurodegenerative disorders caused by expression of proteins containing expanded polyglutamine tracts. Great progress has been made in elucidating the molecular mechanisms contributing to polyglutamine pathology, and in identifying potential drug targets. Although much remains to be learned, these advances provide an opportunity for rational approaches to target-based drug discovery. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
